Circulating CCRR serves as potential novel biomarker for predicting acute myocardial infarction

Cold regions exhibit a high prevalence of cardiovascular disease, particularly acute myocardial infarction (AMI), which is one of the leading causes of death associated with cardiovascular conditions. Cardiovascular disease is closely linked to the abnormal expression of long non-coding RNA (lncRNA)...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuan Lina, Luo Huishan, Wang Shu, Wang Guangze, Yang Xingmei, Chen Jun, Guo Jianjun, Duan Xiaomeng, Li Xiufang, Yang Hua, Wang Shengjie, Zhang Hailong, Zhang Qingqing, Liu Shulei, She Yongtao, Kang Kai, Sun Lihua
Format: Article
Language:English
Published: De Gruyter 2024-11-01
Series:Frigid Zone Medicine
Subjects:
Online Access:https://doi.org/10.1515/fzm-2024-0015
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846162219705827328
author Xuan Lina
Luo Huishan
Wang Shu
Wang Guangze
Yang Xingmei
Chen Jun
Guo Jianjun
Duan Xiaomeng
Li Xiufang
Yang Hua
Wang Shengjie
Zhang Hailong
Zhang Qingqing
Liu Shulei
She Yongtao
Kang Kai
Sun Lihua
author_facet Xuan Lina
Luo Huishan
Wang Shu
Wang Guangze
Yang Xingmei
Chen Jun
Guo Jianjun
Duan Xiaomeng
Li Xiufang
Yang Hua
Wang Shengjie
Zhang Hailong
Zhang Qingqing
Liu Shulei
She Yongtao
Kang Kai
Sun Lihua
author_sort Xuan Lina
collection DOAJ
description Cold regions exhibit a high prevalence of cardiovascular disease, particularly acute myocardial infarction (AMI), which is one of the leading causes of death associated with cardiovascular conditions. Cardiovascular disease is closely linked to the abnormal expression of long non-coding RNA (lncRNA). This study investigates whether circulating levels of lncRNA cardiac conduction regulatory RNA (CCRR) could serve as a biomarker for AMI.
format Article
id doaj-art-19735a17d07b4f25a6e275ab513d0339
institution Kabale University
issn 2719-8073
language English
publishDate 2024-11-01
publisher De Gruyter
record_format Article
series Frigid Zone Medicine
spelling doaj-art-19735a17d07b4f25a6e275ab513d03392024-11-20T15:34:37ZengDe GruyterFrigid Zone Medicine2719-80732024-11-014313715110.1515/fzm-2024-0015Circulating CCRR serves as potential novel biomarker for predicting acute myocardial infarctionXuan Lina0Luo Huishan1Wang Shu2Wang Guangze3Yang Xingmei4Chen Jun5Guo Jianjun6Duan Xiaomeng7Li Xiufang8Yang Hua9Wang Shengjie10Zhang Hailong11Zhang Qingqing12Liu Shulei13She Yongtao14Kang Kai15Sun Lihua16Department of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Joint International Research Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin150000, ChinaDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Joint International Research Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin150000, ChinaDepartment of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin150000, ChinaDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Joint International Research Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin150000, ChinaDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Joint International Research Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin150000, ChinaDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Joint International Research Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin150000, ChinaDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Joint International Research Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin150000, ChinaDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Joint International Research Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin150000, ChinaDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Joint International Research Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin150000, ChinaDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Joint International Research Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin150000, ChinaDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Joint International Research Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin150000, ChinaDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Joint International Research Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin150000, ChinaDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Joint International Research Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin150000, ChinaDepartment of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin150000, ChinaDepartment of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin150000, ChinaDepartment of Cardiovascular Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin150000, ChinaDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Joint International Research Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin150000, ChinaCold regions exhibit a high prevalence of cardiovascular disease, particularly acute myocardial infarction (AMI), which is one of the leading causes of death associated with cardiovascular conditions. Cardiovascular disease is closely linked to the abnormal expression of long non-coding RNA (lncRNA). This study investigates whether circulating levels of lncRNA cardiac conduction regulatory RNA (CCRR) could serve as a biomarker for AMI.https://doi.org/10.1515/fzm-2024-0015acute myocardial infarctionlncrnacardiac conduction regulatory rnaexosome
spellingShingle Xuan Lina
Luo Huishan
Wang Shu
Wang Guangze
Yang Xingmei
Chen Jun
Guo Jianjun
Duan Xiaomeng
Li Xiufang
Yang Hua
Wang Shengjie
Zhang Hailong
Zhang Qingqing
Liu Shulei
She Yongtao
Kang Kai
Sun Lihua
Circulating CCRR serves as potential novel biomarker for predicting acute myocardial infarction
Frigid Zone Medicine
acute myocardial infarction
lncrna
cardiac conduction regulatory rna
exosome
title Circulating CCRR serves as potential novel biomarker for predicting acute myocardial infarction
title_full Circulating CCRR serves as potential novel biomarker for predicting acute myocardial infarction
title_fullStr Circulating CCRR serves as potential novel biomarker for predicting acute myocardial infarction
title_full_unstemmed Circulating CCRR serves as potential novel biomarker for predicting acute myocardial infarction
title_short Circulating CCRR serves as potential novel biomarker for predicting acute myocardial infarction
title_sort circulating ccrr serves as potential novel biomarker for predicting acute myocardial infarction
topic acute myocardial infarction
lncrna
cardiac conduction regulatory rna
exosome
url https://doi.org/10.1515/fzm-2024-0015
work_keys_str_mv AT xuanlina circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT luohuishan circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT wangshu circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT wangguangze circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT yangxingmei circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT chenjun circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT guojianjun circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT duanxiaomeng circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT lixiufang circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT yanghua circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT wangshengjie circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT zhanghailong circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT zhangqingqing circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT liushulei circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT sheyongtao circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT kangkai circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction
AT sunlihua circulatingccrrservesaspotentialnovelbiomarkerforpredictingacutemyocardialinfarction